Clinical trial
Simultaneous Pancreas-kidney Transplantation With Campath Protocol
NCT00316810 · Dr. Claudia Bösmüller, Other · Completed
Key facts
| NCT number | NCT00316810 |
|---|---|
| Title | Simultaneous Pancreas-kidney Transplantation With Campath Protocol |
| Official title | An Open-label, Randomized, Prospective Study to Investigate the Safety and Efficacy of Campath-1H as an Induction Agent in Combination With Tacrolimus Monotherapy Compared to Short-course ATG-induction in Combination With Tacrolimus, Mycophenolate Mofetil and Short-term Steroids Application in de… |
| Lead sponsor | Dr. Claudia Bösmüller, Other |
| Collaborators | Astellas Pharma GmbH Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Pancreas-Kidney Transplantation |
| Intervention type | Drug |
| Interventions | Alemtuzumab, Rabbit Anti-Human Thymocyte Globulin |
| Enrollment | 30 |
| Start date | Apr 1, 2006 |
| Primary completion | Feb 1, 2011 |
| Completion | Jun 1, 2011 |
| First posted | Apr 21, 2006 |
| Last update posted | Jun 19, 2012 |
| Countries | Austria |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: